Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Lesalpes29on Sep 03, 2022 7:10am
205 Views
Post# 34939863

RE:RE:RE:RE:RE:RE:RE:Re medical vs business buckhenry

RE:RE:RE:RE:RE:RE:RE:Re medical vs business buckhenry
canadafan wrote: d like to add yet another, seldom discussed side on ONC Pelareorep. Point: There are a handful of trials we have named & talked about repeatedly. How about the 100 or so people ( patients in trials), who wake up every day with hope. hope of progress from Pela & other combo treatments. Yet, perhaps at bed time sleep in fear of treatment failure. Do they own shares in Onc? Maybe, maybe not. Their “lottery” is not measured in SP, Market cap, daily trading volume. They no doubt along with their families hope & pray for success. THAT is an investment. let that sink in a while …


IT'S a waiting game now. You can choose to do it patiently and holding your shares or sell because it's taking too much time or it's too risky. I'm on the wait side but I can be wrong of course!
<< Previous
Bullboard Posts
Next >>